22 August 2023

A clinical trial at Bellvitge Hospital shows that the experience of patients undergoing chest drain removal after heart surgery improves with the incorporation of this immersive practic

10 August 2023

Bellvitge University Hospital (HUB) is set to introduce advanced magnetic resonance imaging (MRI) equipment within the premises of the Delta building, its hub of excellence in Neuroscience and Neurosurgery. This cutting-edge apparatus is specifically designed to cater to the diagnosis and treatment of patients grappling with a spectrum of neurological disorders, encompassing both medical and surgical cases. It will entirely integrate into the hospital's operational workflows.

08 August 2023

Dr Josep Manuel Menchon, group leader at IDIBELL and Head of Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire (UK) to address and reduce the risks of harmful internet use among adolescents.

08 August 2023
With this organizational change, clinical psychologists have been brought together within a dedicated, independent, and cross-functional unit that caters to patients from across Bellvitge University Hospital (HUB).
01 August 2023
The Pancreatic Surgery Unit of the General and Digestive Surgery Service at Bellvitge University Hospital, in the year 2022, successfully conducted a total of 54 cephalic duodenopancreatectomies, out of which 8 were carried out using minimally invasive techniques, such as robotic or laparoscopic procedures. All of these surgeries were completed without any recorded mortality.
27 July 2023

According to the results of the APRIL study, in which the Bellvitge University Hospital (HUB) and IDIBELL have participated, ApTOLL has shown good safety in 151 patients with acute ischaemic stroke. The study also highlights that preliminary efficacy results show that the drug significantly reduces mortality and long-term functional disability.